Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
European Urology Oncology|April 6, 2024
Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer: Further Results from the Phase 3 PROpel TrialFred Saad, Andrew J Armstrong, Mototsugu Oya, et al.
Cancer Investigation|May 15, 2026
Prognostic Impact of TP53 and RB1 Alterations in Metastatic Castration-Resistant Prostate Cancer Treated with DocetaxelJa Yoon Heo, Chung Lee, Heesun Shin, et al.
Cancer Cell|September 6, 2008
Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agentsYuval Shaked, Erik Henke, Jeanine M L Roodhart, et al.
Genes|September 28, 2023
Predicting Patterns of Distant Metastasis in Breast Cancer Patients following Local Regional Therapy Using Machine LearningAudrey Shiner, Alex Kiss, Khadijeh Saednia, et al.
Journal of Geriatric Oncology|October 10, 2022
The development of an electronic geriatric assessment tool: Comprehensive health assessment for my plan (CHAMP)Simon Cook, Cosmin Munteanu, Efthymios Papadopoulos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2021
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or EnzalutamideKatherine A Zukotynski, Urban Emmenegger, Sebastien Hotte, et al.
Journal of Geriatric Oncology|March 23, 2024
TOward a comPrehensive supportive Care intervention for Older men with metastatic Prostate cancer (TOPCOP3): A pilot randomized controlled trial and process evaluationShabbir M H Alibhai, Martine Puts, Rana Jin, et al.
European Urology Oncology|June 26, 2024
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort DEvan Y Yu, Cristiano Ferrario, Mark D Linch, et al.
European Urology Oncology|November 8, 2023
Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate-Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 StudyEvan Y Yu, William R Berry, Howard Gurney, et al.
European Urology|April 10, 2022
Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B StudyEvan Y Yu, Michael P Kolinsky, William R Berry, et al.
Pageof 10